Hjem › Hypofarynxcancer › Iowa › Cedar Rapids
Kliniske studier for Hypofarynxcancer i Cedar Rapids, IA
4 studier for Hypofarynxcancer søker deltakere på steder i og rundt Cedar Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruttererFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Hypofarynxcancer-studier i andre byer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Kansas City, MO5 studier
- Richmond, VA5 studier
- Wausau, WI5 studier
- Bloomington, IL5 studier
- Stevens Point, WI5 studier
- Cape Girardeau, MO5 studier
- Peoria, IL5 studier
- Milwaukee, WI5 studier
- Joliet, IL5 studier
- Overland Park, KS4 studier
Andre studier i Cedar Rapids
- Ikke-småcellet lungekreft20 studier
- Brystkreft17 studier
- Kreft (alle typer)16 studier
- Akut myelogen leukemi16 studier
- Multipelt myelom15 studier
- Lungekreft14 studier
- Kolorektal kreft13 studier
- Plateepitelcancer i hode og hals12 studier
- Prostatakreft12 studier
- Slag10 studier
- Melanom10 studier
- Endometriekreft9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.